British Journal of Cancer

FIGURES AND TABLES

FROM:

Recent clinical studies of the immunomodulatory drug (IMiD®) lenalidomide

J B Bartlett, A Tozer, D Stirling and J B Zeldis

BACK TO ARTICLEBACK TO ARTICLE